Home > Publishers > Global Markets Direct
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Publisher
Filter

Global Markets Direct Report List

labd
Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Filter
Title Search
1 - 25 of 1190 Products Sort by Display
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074449
Published
April 29, 2022
Content info
100 Pages
Price
USD 3500
Sample available
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074448
Published
April 29, 2022
Content info
138 Pages
Price
USD 3500
Sample available
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074447
Published
April 29, 2022
Content info
152 Pages
Price
USD 3500
Sample available
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074446
Published
April 29, 2022
Content info
119 Pages
Price
USD 3500
Sample available
Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074445
Published
April 29, 2022
Content info
133 Pages
Price
USD 3500
Sample available
Cell Division Protein FtsZ (ftsz) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074444
Published
April 29, 2022
Content info
36 Pages
Price
USD 3500
Sample available
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074443
Published
April 29, 2022
Content info
71 Pages
Price
USD 3500
Sample available
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074442
Published
April 29, 2022
Content info
45 Pages
Price
USD 3500
Sample available
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074441
Published
April 29, 2022
Content info
64 Pages
Price
USD 3500
Sample available
Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074440
Published
April 29, 2022
Content info
127 Pages
Price
USD 2000
Sample available
Bronchopulmonary Dysplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074439
Published
April 29, 2022
Content info
69 Pages
Price
USD 2000
Sample available
Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074438
Published
April 29, 2022
Content info
37 Pages
Price
USD 2000
Sample available
Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074437
Published
April 29, 2022
Content info
62 Pages
Price
USD 2000
Sample available
Ocular Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074436
Published
April 29, 2022
Content info
112 Pages
Price
USD 2000
Sample available
Juvenile Macular Degeneration (Stargardt Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074435
Published
April 29, 2022
Content info
96 Pages
Price
USD 2000
Sample available
Blepharitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074434
Published
April 29, 2022
Content info
60 Pages
Price
USD 2000
Sample available
Viral Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074433
Published
April 29, 2022
Content info
40 Pages
Price
USD 2000
Sample available
Synovial Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074432
Published
April 29, 2022
Content info
136 Pages
Price
USD 2000
Sample available
Fibrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074431
Published
April 29, 2022
Content info
73 Pages
Price
USD 2000
Sample available
Leiomyosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074430
Published
April 29, 2022
Content info
152 Pages
Price
USD 2000
Sample available
Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074429
Published
April 29, 2022
Content info
342 Pages
Price
USD 2500
Sample available
Rectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074428
Published
April 29, 2022
Content info
131 Pages
Price
USD 2000
Sample available
Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074427
Published
April 29, 2022
Content info
216 Pages
Price
USD 2000
Sample available
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074426
Published
April 29, 2022
Content info
316 Pages
Price
USD 2500
Sample available
Polycythemia Vera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published by
Global Markets Direct
Product code
1074425
Published
April 29, 2022
Content info
107 Pages
Price
USD 2000
Sample available
Compare
item is currently selected
Compare products
Delete all